| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |